Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Clinical validation of the gastrointestinal NET grading system: Ki67 index criteria of the WHO 2010 classification is appropriate to predict metastasis or recurrence.

Yamaguchi T, Fujimori T, Tomita S, Ichikawa K, Mitomi H, Ohno K, Shida Y, Kato H.

Diagn Pathol. 2013 Apr 22;8:65. doi: 10.1186/1746-1596-8-65.

2.
3.

Somatostatin analogues according to Ki67 index in neuroendocrine tumours: an observational retrospective-prospective analysis from real life.

Faggiano A, Carratù AC, Guadagno E, Tafuto S, Tatangelo F, Riccardi F, Mocerino C, Palmieri G, Damiano V, Siciliano R, Leo S, Mauro A, Tozzi LF, Battista C, De Rosa G, Colao A.

Oncotarget. 2016 Feb 2;7(5):5538-47. doi: 10.18632/oncotarget.6686.

4.

The Ki-67 labeling index and lymphatic/venous permeation predict the metastatic potential of rectal neuroendocrine tumors.

Sugimoto S, Hotta K, Shimoda T, Imai K, Yamaguchi Y, Nakajima T, Oishi T, Mori K, Takizawa K, Kakushima N, Tanaka M, Kawata N, Matsubayashi H, Ono H.

Surg Endosc. 2016 Oct;30(10):4239-48. doi: 10.1007/s00464-015-4735-3. Epub 2015 Dec 30.

PMID:
26718357
5.

Recent Updates on Neuroendocrine Tumors From the Gastrointestinal and Pancreatobiliary Tracts.

Kim JY, Hong SM.

Arch Pathol Lab Med. 2016 May;140(5):437-48. doi: 10.5858/arpa.2015-0314-RA. Review.

PMID:
27128301
6.

The Impact of Phosphohistone-H3-Assisted Mitotic Count and Ki67 Score in the Determination of Tumor Grade and Prediction of Distant Metastasis in Well-Differentiated Pancreatic Neuroendocrine Tumors.

Ozturk Sari S, Taskin OC, Gundogdu G, Yegen G, Onder S, Keskin M, Saglam S, Ozluk Y, Gulluoglu M, Mete O.

Endocr Pathol. 2016 Jun;27(2):162-70. doi: 10.1007/s12022-016-9424-9.

PMID:
26936845
7.

Ki-67 cytological index can distinguish well-differentiated from poorly differentiated pancreatic neuroendocrine tumors: a comparative cytohistological study of 53 cases.

Carlinfante G, Baccarini P, Berretti D, Cassetti T, Cavina M, Conigliaro R, De Pellegrin A, Di Tommaso L, Fabbri C, Fornelli A, Frasoldati A, Gardini G, Losi L, Maccio L, Manta R, Pagano N, Sassatelli R, Serra S, Camellini L.

Virchows Arch. 2014 Jul;465(1):49-55. doi: 10.1007/s00428-014-1585-7. Epub 2014 May 8.

PMID:
24807732
8.

Variability of Ki67 labeling index in multiple neuroendocrine tumors specimens over the course of the disease.

Singh S, Hallet J, Rowsell C, Law CH.

Eur J Surg Oncol. 2014 Nov;40(11):1517-22. doi: 10.1016/j.ejso.2014.06.016. Epub 2014 Jul 24.

PMID:
25088936
9.

Analysis of risk factors for recurrence after curative resection of well-differentiated pancreatic neuroendocrine tumors based on the new grading classification.

Tsutsumi K, Ohtsuka T, Fujino M, Nakashima H, Aishima S, Ueda J, Takahata S, Nakamura M, Oda Y, Tanaka M.

J Hepatobiliary Pancreat Sci. 2014 Jun;21(6):418-25. doi: 10.1002/jhbp.47. Epub 2013 Oct 20.

PMID:
24142395
10.

The novel WHO 2010 classification for gastrointestinal neuroendocrine tumours correlates well with the metastatic potential of rectal neuroendocrine tumours.

Jernman J, Välimäki MJ, Louhimo J, Haglund C, Arola J.

Neuroendocrinology. 2012;95(4):317-24. doi: 10.1159/000333035. Epub 2012 Feb 7.

11.

Comparison of World Health Organization 2000/2004 and World Health Organization 2010 classifications for gastrointestinal and pancreatic neuroendocrine tumors.

Pasaoglu E, Dursun N, Ozyalvacli G, Hacihasanoglu E, Behzatoglu K, Calay O.

Ann Diagn Pathol. 2015 Apr;19(2):81-7. doi: 10.1016/j.anndiagpath.2015.01.001. Epub 2015 Jan 9.

PMID:
25702616
12.

Validation of the 2010 WHO classification and a new prognostic proposal: A single centre retrospective study of well-differentiated pancreatic neuroendocrine tumours.

Ricci C, Casadei R, Taffurelli G, Campana D, Ambrosini V, Pagano N, Santini D, De Giorgio R, Ingaldi C, Tomassetti P, Zani E, Minni F.

Pancreatology. 2016 May-Jun;16(3):403-10. doi: 10.1016/j.pan.2016.02.002. Epub 2016 Feb 16.

PMID:
26924664
13.

Evaluation of the concordance between the stage of the disease and Ki-67 proliferation index in gastroenteropancreatic neuroendocrine tumors.

Özaslan E, Demir S, Karaca H, Güven K.

Eur J Gastroenterol Hepatol. 2016 Jul;28(7):836-41. doi: 10.1097/MEG.0000000000000619.

PMID:
26945127
14.

Objective quantification of the Ki67 proliferative index in neuroendocrine tumors of the gastroenteropancreatic system: a comparison of digital image analysis with manual methods.

Tang LH, Gonen M, Hedvat C, Modlin IM, Klimstra DS.

Am J Surg Pathol. 2012 Dec;36(12):1761-70. doi: 10.1097/PAS.0b013e318263207c.

PMID:
23026928
15.

Clinico-morphological analysis of the neuroendocrine neoplasms of the gastroenteropancreatic system.

Delektorskaya VV, Kozlov NA, Chemeris GY.

Klin Lab Diagn. 2013 Oct;(10):48-50, 10-3. English, Russian.

PMID:
24640093
16.

[Grading of neuroendocrine tumors].

Saeger W, Schnabel PA, Komminoth P.

Pathologe. 2016 Jul;37(4):304-13. doi: 10.1007/s00292-016-0186-4. Review. German.

PMID:
27379621
17.

Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms.

Klöppel G.

Endocr Relat Cancer. 2011 Oct 17;18 Suppl 1:S1-16. doi: 10.1530/ERC-11-0013. Print 2011 Oct. Review.

18.

Grading of well-differentiated pancreatic neuroendocrine tumors is improved by the inclusion of both Ki67 proliferative index and mitotic rate.

McCall CM, Shi C, Cornish TC, Klimstra DS, Tang LH, Basturk O, Mun LJ, Ellison TA, Wolfgang CL, Choti MA, Schulick RD, Edil BH, Hruban RH.

Am J Surg Pathol. 2013 Nov;37(11):1671-7. doi: 10.1097/PAS.0000000000000089.

19.

Grading the neuroendocrine tumors of the lung: an evidence-based proposal.

Rindi G, Klersy C, Inzani F, Fellegara G, Ampollini L, Ardizzoni A, Campanini N, Carbognani P, De Pas TM, Galetta D, Granone PL, Righi L, Rusca M, Spaggiari L, Tiseo M, Viale G, Volante M, Papotti M, Pelosi G.

Endocr Relat Cancer. 2013 Dec 16;21(1):1-16. doi: 10.1530/ERC-13-0246. Print 2014 Feb.

20.

Automated quantification of Ki-67 proliferative index of excised neuroendocrine tumors of the lung.

Liu SZ, Staats PN, Goicochea L, Alexiev BA, Shah N, Dixon R, Burke AP.

Diagn Pathol. 2014 Oct 16;9:174. doi: 10.1186/s13000-014-0174-z.

Supplemental Content

Support Center